Plasma Serotonin Levels and Depression Scores in Informal Caregivers of Patients with Dementia and without Dementia: A Systematic Review
DOI:
https://doi.org/10.26911/theijmed.2026.11.1.913Abstract
Background: Depression frequently affects informal caregivers, particularly those caring for dementia patients due to greater emotional and caregiving burdens. This study aims to compare depression levels and plasma serotonin concentrations between dementia and non-dementia caregivers.
Subjects and Method: A systematic review was conducted using PRISMA guidelines. Articles were searched from PubMed, ScienceDirect, and Google Scholar between 2015–2024 using the keywords: dementia caregiver, non-dementia caregiver, depression, and serotonin. Nine primary observational studies met the inclusion criteria: full-text availability, adult informal caregivers, and quantitative measurement of depression and/or serotonin. Data were synthesized narratively.
Results: Most studies demonstrated higher depression levels among dementia caregivers compared to non-dementia caregivers. Emotional distress, patient behavioral symptoms, and caregiving duration were identified as major contributing factors. One study showed lower plasma serotonin associated with higher depressive scores, supporting possible biological involvement.
Conclusion: Dementia caregivers exhibit greater depressive symptoms than non-dementia caregivers, potentially linked to caregiving burden and serotonin imbalance. Early psychological screening and targeted support interventions are recommended.
Keywords:
Dementia caregivers, depression, serotonin, non-dementia, mental healthReferences
Baumgartner H, Falk V, Lancellotti P, Lan-sac E, Rosenhek R, Sjögren J, Vaha-nian A, et al. (2017). ESC/EACTS Gu-idelines for the management of val-vular heart disease. Eur Heart J. 38: 2739-91. doi: 10.5603/KP.2018.0013.
Biteker M, Tekkesin AI, Can MM, Dayan A, Ilhan E, Türkmen FM (2012). Out-come of non-cardiac and nonvascular surgery in patients with mechanical heart valves. Am J Cardiol. 110: 562-7. doi: 10.1016/j.amjcard.2012.04.031.
Chan WS, Anand S, and Ginsberg JS (2000). Anticoagulation of pregnant women with mechanical heart valves: A systematic review of the literature. Arch Intern Med. 160: 191-6. doi: 10.1001/archinte.160.2.191.
Daniels PR, McBane RD, Litin SC, Ward SA, Hodge DO, Dowling NF, Heit JA, et al. (2009). Periprocedural anticoa-gulation management of mechanical heart valve patients. Thromb Res. 124: 300-5. doi: 10.1016/j.thromres.-2009.01.011.
Douketis JD, Spyropoulos AC, Kaatz S, et al. (2012). Bridging anticoagulation: Is it needed when warfarin is interrupted around the time of a surgery or procedure? Circulation. 125: e496-8. doi: 10.1161/CIRCULATIONAHA.111.084517.
Douketis JD, Spyropoulus AC, Spencer FA, Michael M, Jaffer AK, Eckman MH, Dunn AS, et al. (2012). Perioperative management of antithrombotic the-rapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 141: e326S-50S. doi: 10.1378/chest.08-0675.
Douketis JD, Spyropoulos AC, Kaatz S, Becker RC. 2015. Perioperative bridg-ing anticoagulation in patients with atrial fibrillation. N Eng J Med. 373(9): 823-33. doi: 10.1056/NEJMoa1501035. Epub 2015 Jun 22.
Eijgenraam P, ten Cate H, and ten Cate-Hoek AJ (2014). The practice of bridging anticoagulation: guideline adherence and risk factors for bleeding. Neth J Med. 72(3): 157-64. https://-pubmed.ncbi.nlm.nih.gov/24846933/
Fleiser LA, Fleischmann KE, Aurbach AD, Bernason SA, Beckman JA, Bozkurt B, Davila-Roman VG, et al (2014). ACC/AHA Guideline on perioperative cardiovascular evaluation and management of patients undergoing non-cardiac surgery. J Am Coll Cardiol. 64(22): e77-137. doi: 10.1161/CIR.00000-00000000105
Hassouna A and Allam H (2014). Limited dose warfarin throughout pregnancy in patients with mechanical heart valve prosthesis: A meta-analysis. Interact Cardiovasc Thorac Surg. 18: 797-806. doi: 10.1093/icvts/ivu009
Keeling D, Baglin T, Taite C, Watson H, Perry D, Baglin C, Kitchen S, et al (2011). Guidelines on oral anticoagulation with warfarin-fourth edition. Br J Haematol. 154(3): 311-24. doi: 10.1111/j.1365-2141.2011.08753.x
Kirley K, Qato DM, Kornfield R, Stafford RS, Alexander GC (2012). National trends in oral anticoagulant use in the United States, 2007 to 2012. Circ Cardiovasc Qual. 5: 615-21. doi: 10.1161/CIRC-OUTCOMES.112.967299.
Kristensen SD, Knuuti J, Saraste A, Anker S, Hert SD, Ford I, Gonzalez-Juanatey R, et al (2014). ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management. Eur Heart J. 35: 2383-431. doi: 10.1093/eurheartj/ehu282. Epub 2014 Aug 1.
Moesker MJ, de Groot JF, Damen NL, Bij-sterveld NR, Twisk JWR, Huisman MV, Wagner C, et al (2019). Guideline compliance for bridging anticoagulation use in vitamin-K antagonist patients; practice variation and factors associated with non-compliance. Throm J. 17:15. doi: 10.1186/s12959-019-0204-x.
Nishimura RA, Otto CM, Bonow RO, Cara-bello BA, Erwinlll JP, Guyton RA, O’Gara PT, et al (2014). AHA/ACC Guideline for the management of pa-tients with valvular heart disease. J Am Coll Cardiol. 63(22): e57-185. doi: 10.1161/CIR.0000000000000029.
Nishimura RA, Otto CM, Bonow RO, Cara-bello BA, Erwinlll JP, Guyton RA, O’-Gara PT, et al (2017). 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the management of patients with valvular heart disease. J Am Coll Cardiol. 70(2): 252-89. doi: 10.1161/CIR.0000000000000503.
Rechenmacher SJ, Fang JC (2015). Bridg-ing anticoagulation. J Am Coll Cardiol. 66(12): 392-403. doi: 10.1016/j.jacc.2015.08.002.
Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Bonis MD, Lung B, Johnson MR, Kintscher U, Kranke P, et al (2018). ESC Guideline for the management of cardiovascular diseases during pregnancy. Eur Heart J. 00: 1-83. doi: 10.1093/eurheartj/ehy340.
Shaikh SI, Kumari RV, Hegade G, Maru-theesh M (2017). Perioperative consi-derations and management of patients receiving anticoagulants. Anesth Essays Res. 11(1): 10-16. doi: 10.4103/0259-1162.179313.
Siegal D, Yudin J, Kaatz S, Douketis JD, Lim W, Spyropoulos AC (2012). Periprocedural heparin bridging in patients receiving vitamin K antagonists: a systematic review and meta-analysis of bleeding and thromboembolic rates. Circulation. 126: 1630-9. doi: 10.1161/-CIRCULATIONAHA.112.105221.
Tafur AJ, McBane R, Wysokinski WE, Litin S, Daniels P, Slusser J, Hodge D, Beckman G, et al (2012). Predictors major bleeding in periprocedural anticoagulation management. J Thromb Haemost. 10(2): 261-7. doi: 10.1111/j.1538-7836.2011.04572.x.
Tafur AJ, Douketis J (2018). Perioperative management of anticoagulant and antiplatelet therapy. Heart. 104. 14-61-7. doi: 10.1136/heartjnl-2016-310581.
Tan CW, Wall M, Rosengart TK, Rosengart TK, Ghanta RK (2019). How to bridge? Management of anticoagulation in patients with mechanical heart valves undergoing non-cardiac surgical procedures. J Thorac Cardiovascular Surg. 158(1): 200-3. doi: 10.1016/j.jtcvs.2018.-06.089. Epub 2018 Jul 20.
Van Hagen IM, Roos-Hesselink JW, Ruys TP, Merz WM, Goland S, Gabriel H, Lelonek M, et al. (2015). Pregnancy in women with a mechanical heart valve: Data of the European Society of Cardiology Registry of Pregnancy and Cardiac Disease (ROPAC). Circulation. 132: 132-42. doi: 10.1161/CIRCULATION-AHA.115.015242.
Whitlock RP, Sun JC, Fremes SE, Rubens FD, Teoh KH. 2012. Antithrombotic and thrombolytic therapy for valvular heart disease: antithrombotic therapy and prevention of thrombosis, 9th Ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 141(2): e576S-600S. doi: 10.1378/chest.11-2305.
Wysokinski WE and McBane RD II (2012). Periprocedural bridging management of anticoagulation. Circulation. 126: 486-90. doi: 10.1161/CIRCULATION-AHA.112.092833.
Xu Z, Fan J, Luo X, Zhang W, Ma J, Lin Y, Ma S, et al (2016). Anticoagulation regimens during pregnancy in patients with mechanical heart valves: A systematic review and meta-analysis. Can J Cardiol. 32: 1248.e1-1248.e9. doi: 10.1016/j.cjca.2015.11.005.
